Australia seems poised to gain access to potentially transformative therapy for obesity: Retatrutide. This dual molecule – targeting on both GLP-1 and GIP receptors – has promising outcomes in global trials, https://retatrutideaustraliatrea657109.blogdon.net/the-new-retatrutide-australia-a-hope-for-losing-weight-57894061